S. Rangaratnam

Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.

R. Weksberg, G. Rouleau, V. Riccardi, 1996, American journal of human genetics.

Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas

Olivier Delattre, G. Thomas, O. Delattre, 1994, Nature Genetics.

Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene.

G. Rouleau, J. Delattre, M. Poisson, 1996, Cancer genetics and cytogenetics.